Showing 81 - 100 results of 125 for search '808 State', query time: 0.05s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84

    An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers by Xiaoliang Qi, Yajing Xiang, Ying Li, Jiajia Wang, Yuxi Chen, Yulong Lan, Jinsong Liu, Jianliang Shen

    Published 2025-03-01
    “…Once optimal antibacterial action is reached, ISD3 switches to a dormant state, halting any further ROS production. Moreover, the bioactive components in ISD3 can exert anti-inflammatory functions, aiding in pressure ulcer recovery. …”
    Get full text
    Article
  5. 85
  6. 86
  7. 87

    Optimizing Obstructive Sleep Apnea Risk Assessment in Hypertension: Development of a Predictive Nomogram in China by Yang Y, Sun X, Liang J, Liao WF, Ye W, Zheng Z, Du L, Chen M, Zhang Y, Lin W, Huang J, Yao W, Chen R

    Published 2025-02-01
    “…The C-index is 0.840 in the training group and 0.808 in the validation group. The area under the curve (AUC) of the predictive model and STOP-Bang at the three diagnostic cut-off points of the Apnea-Hypopnea Index (AHI) ≥ 5, AHI ≥ 15 and AHI ≥ 30 were 0.840 vs 0.778, 0.754 vs 0.740, and 0.765 vs 0.751 respectively. …”
    Get full text
    Article
  8. 88

    Predatory Functional Response of Harmonia sedecimnotata to Aphis craccivora by Jiaru DENG, Zhiwei LIU, Lizhi HUO, Longhua SUN

    Published 2024-11-01
    “…In practical application, suitable insect state and quantity should be adopted according to the occurrence density of A. craccivora.…”
    Get full text
    Article
  9. 89

    Acute kidney injury and outcomes in hospitalized children with autoimmune rheumatic disease by Chien-Hung Lin, Wen-Sheng Liu, Chuan Wan, Hsin-Hui Wang

    Published 2025-02-01
    “…Methods A retrospective analysis was conducted using the United States Nationwide Inpatient Sample (NIS) database from 2005 to 2020. …”
    Get full text
    Article
  10. 90
  11. 91

    Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial by Pavlos Msaouel, Kai Yu, Ying Yuan, Jianfeng Chen, Xinmiao Yan, Menuka Karki, Fei Duan, Rahul A. Sheth, Priya Rao, Kanishka Sircar, Amishi Y. Shah, Amado J. Zurita, Giannicola Genovese, Min Li, Chih-Chen Yeh, Minghao Dang, Guangchun Han, Yanshuo Chu, Max Hallin, Peter Olson, Rui Yang, Daniela Slavin, Hirak Der-Torossian, Curtis D. Chin, Nizar M. Tannir, Linghua Wang, Jianjun Gao

    Published 2025-01-01
    “…Treatment resistance was characterized by a transition from cytotoxic to exhausted T cell state and enrichment for M2-like myeloid cells. The observed hypothesis-generating changes in gene expression dynamics and cellular states may help inform future strategies to optimize immunotherapy efficacy. …”
    Get full text
    Article
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96

    Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe by Emilijus Žilinskas, Arūnas Vaitkevičius

    Published 2024-03-01
    “…Commercial clinical trials have more participants, and are more commonly conducted in multiple member states. …”
    Get full text
    Article
  17. 97
  18. 98
  19. 99
  20. 100

    Analyzing the serum biochemical factors that influence early neurological deterioration in ischemic Stroke patients and developing a nomogram prediction model by Xiaoni Zhan, Yunyun Xu, Rongrong Ma

    Published 2025-01-01
    “…Hcy had an area under the curve of 0.808 (95% CI:0.750 to 0.858), with 79.71% sensitivity and 70.20% specificity. …”
    Get full text
    Article